Full Fed. Circ. Won't Take On Teva's Orange Book Appeal
By Bonnie Eslinger · March 3, 2025, 10:02 PM EST
The Federal Circuit on Monday rejected a request for an en banc rehearing from Teva Pharmaceuticals challenging a panel decision finding that the company improperly listed its asthma inhaler patents on...
To view the full article, register now.